OncoCyte (OCX) Misses Q2 EPS by 36c
Tweet
Share
E-mailGet Alerts OCX Hot Sheet
Join SI Premium – FREE
OncoCyte (NASDAQ: OCX) reported Q2 EPS of ($0.36). Revenue for the quarter came in at $100 thousand.
For earnings history and earnings-related data on OncoCyte (OCX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ExxonMobil Q2 profit falls short of forecasts, shares slide
- Colgate-Palmolive tops EPS estimates, but shares dip
- Chevron beats estimates as oil prices surge, shares rise
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
